Alex Goolsby positions clients to anticipate and capitalize on market shifts through competitive analysis and strategy design, including service and product diversification, capabilities integration, and market identification and selection.

He provides strategic and operational advisory services to the spectrum of healthcare stakeholders, including multi-facility delivery systems and medical groups, commercial payers, pharmaceutical and device manufacturers, and associations and consumer groups.

Prior to Avalere, Alex held leadership roles at Kaiser Permanente, Huron Consulting, and the National Academy of Medicine.

Alex earned an MBA from Duke University’s Fuqua School of Business and an MSPH at UNC’s Gillings School of Global Public Health. He studied chemistry at Colgate University.

Authored Content

While the HEDIS® collection season lasts for a limited time, the focus on initiatives that impact HEDIS results is a year-round priority. The period between submission and HEDIS season ramp-up, known as the “off-season,” offers an opportunity for health plans to elevate the member experience, amplify quality improvement activities, and improve HEDIS submission effectiveness.

Tune in as our experts discuss the key differences making the the Patient-Perspective Value Framework 1.0 (PPVF) unique compared to value frameworks currently in the market.

Avalere recently partnered with the National Pharmaceutical Council to examine payers' perspectives regarding the use of patient data and how it can be used to shape care delivery, improve system efficiencies, and achieve better health outcomes.

In our patient engagement series, hear Alex Goolsby discuss opportunities for provider organizations, health plans, patient advocacy groups, and drug and device manufacturers to engage patients through education and collaboration to improve healthcare.